We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > non-Hodgkin lymphoma

News List

Forty Seven’s anti-CD47 combo shows promise in non-Hodgkin lymphoma fiercebiotech
November 02, 2018
An immunotherapy combining Roche’s blood cancer drug Rituxan and an anti-CD47 drug developed at Stanford University shrank the cancers of half the patients in a small phase 1 trial.
New Treatment for Non-Hodgkin Lymphoma Approved drugs
August 09, 2018
Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.
FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma drugs
August 09, 2018
Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two rare types of non-Hodgkin lymphoma.